Roche nabs European approval for second Eli Lilly-partnered Alzheimer’s test
Roche has grabbed a European CE mark for its second Alzheimer’s test that can both confirm the disease and help rule it out. Roche has secured a European CE mark for its second Alzheimer’s test that can both help confirm the disease and rule it out. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce 50 Special Report Awards Gala Awards Outsourcing Awards Innovation Awards Resources Fierce Events Industry Events…

Roche has secured a European CE mark for its second Alzheimer’s test that can both help confirm the disease and rule it out.
Source: FierceBiotech